1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEWAMSTERDAM PHARMA COMPANY NV
NewAmsterdam Pharma Company NV XNAS: NAMS

NewAmsterdam Pharma Co NV Live Stock Price Today, Share Analysis and Chart

about

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, i...

Read More
35.46 1.18 (3.44%)
152.20% Gain from 52W Low
697.8K
XNAS Volume

XNAS 27 Feb, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Insider Trade
Michael Davidson, CEO and Director of NewAmsterdam Pharma, sells 300K shares worth $10.6 million See details
Durability score
Not Eligible
Valuation Score
Expensive Valuation
1.7 / 100
Momentum Score
Technically Moderately Bullish
64.7 / 100
Analyst Price Target
49
1Yr Price target upside is 38%
13 analysts

14

S

7

W

6

O

1

T

SWOT Analysis

NewAmsterdam Pharma Co NV Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..